Offer - Urjas Oil for just ₹ 1 X
Onconase 5000 Injection, a prescription drug, is manufactured in various forms such as Injection. It is typically used for the treatment of Blood Cancer.
The right dosage of Onconase 5000 Injection depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Onconase 5000 Injection include Rash, Nausea or vomiting, Increased Liver Enzymes. Normally, these side effects of Onconase 5000 Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Onconase 5000 Injection is Moderate for pregnant women and Severe for women who are breastfeeding. Further, the section on Onconase 5000 Injection related warnings talks about Onconase 5000 Injection's effects on the liver, heart and kidney.
Onconase 5000 Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Onconase 5000 Injection in conditions like Bleeding, Pancreatitis. Other conditions have been mentioned below in the Onconase 5000 Injection contraindications section.
Besides this, Onconase 5000 Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Onconase 5000 Injection is not safe while driving, and is is not addictive in nature.
Onconase 5000 Injection is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Onconase 5000 Injection safe for pregnant women?
Onconase may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Onconase again without your doctor's advice.
Is the use of Onconase 5000 Injection safe during breastfeeding?
Onconase may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Onconase 5000 Injection on the Kidneys?
Onconase rarely affects the kidneys.
What is the effect of Onconase 5000 Injection on the Liver?
The liver can be affected by Onconase. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Onconase only after medical advice.
What is the effect of Onconase 5000 Injection on the Heart?
Onconase is not harmful for the heart.
If you are suffering from any of the following diseases, you should not take Onconase 5000 Injection unless your doctor advises you to do so -
Is this Onconase 5000 Injection habit forming or addictive?
Onconase 5000 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Onconase 5000 Injection, you should not drive or work on any heavy machine, as Onconase 5000 Injection can make you drowsy.
Is it safe?
Yes, but consume Onconase 5000 Injection only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Onconase 5000 Injection for mental disorders.
Interaction between Food and Onconase 5000 Injection
Taking Onconase 5000 Injection with food is safe.
Interaction between Alcohol and Onconase 5000 Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Onconase 5000 Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Elspar® (Asparaginase)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 868-869
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 190-191